lamotrigine has been researched along with olanzapine in 70 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.43) | 18.2507 |
| 2000's | 45 (64.29) | 29.6817 |
| 2010's | 20 (28.57) | 24.3611 |
| 2020's | 4 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Janowsky, DS | 1 |
| Nemeroff, CB | 1 |
| McIntyre, RS | 1 |
| Shelton, RC | 1 |
| Keck, PE | 1 |
| Grof, P | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Dittmann, S; Grunze, H | 1 |
| Kass, E; Klein, RM; Lewis, FT | 1 |
| Ghaemi, SN; Hsu, DJ; Pardo, TB | 1 |
| Ball, JR; Malhi, GS; Mitchell, PB | 1 |
| Halfon, O; Holzer, L | 1 |
| Oral, ET; Vahip, S | 1 |
| Schatzberg, AF | 1 |
| Bowden, CL | 1 |
| Curtis, V | 1 |
| Alda, M; Baruch, P; Beaulieu, S; Connolly, M; Daigneault, A; Gorman, CP; Kennedy, SH; MacQueen, G; McIntyre, R; Milev, R; O'Donovan, C; Parikh, S; Ravindran, A; Schaffer, A; Sharma, V; Silverstone, P; Yatham, LN; Young, LT | 1 |
| Andrews, G; Page, AC | 1 |
| Calabrese, JR; Gao, K | 1 |
| Reiss, JP; Sam, D; Sareen, J | 1 |
| Abbott, R; Ascher, J; Bullman, J; Francis, E; Job, S; Sidhu, J; Theis, JG | 1 |
| Awad, EA; Hon, YY; Jann, MW; Shamsi, SA; Spratlin, V; Zheng, J | 1 |
| Ginsberg, LD | 1 |
| Burch, SP; Calvert, NW; Fu, AZ; Reeves, P; Thompson, TR | 1 |
| Desarkar, P; Sinha, VK | 1 |
| Adams, DH; Brown, EB; Deldar, A; Keck, PE; McElroy, SL; Tohen, M; Williamson, DJ | 1 |
| Atagun, I; Kaya, MC; Kurt, E; Oral, ET; Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
| Chou, JC; Fazzio, L | 1 |
| D'Amico, G; D'Arrigo, C; Micò, U; Migliardi, G; Muscatello, MR; Perucca, E; Santoro, V; Spina, E | 1 |
| Beaulieu, S; Kennedy, SH; MacQueen, G; McIntyre, RS; O'Donovan, C; Parikh, SV; Sharma, V; Yatham, LN | 1 |
| Cruz, N; Sánchez-Moreno, J; Vieta, E | 1 |
| Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
| Alda, M; Duffy, A; Garnham, J; Macdougall, M; Munro, A; O'Donovan, C; Passmore, M; Slaney, C; Teehan, A | 1 |
| Berk, M; Calabrese, JR; Malhi, GS; Mitchell, PB; Ng, F; Tohen, M; Wang, WV | 1 |
| Derry, S; Moore, RA | 1 |
| Barbieri, M; Beynon, S; Bravo Vergel, Y; Duffy, S; Dunn, G; Geddes, J; Gilbody, S; Palmer, S; Soares-Weiser, K; Woolacott, N | 1 |
| Amore, M; Koukopoulos, A; Raggi, MA; Sani, G; Saracino, MA | 1 |
| Berger, W; Fontenelle, LF; Kinrys, G; Mendlowicz, MV; Portella, CM | 1 |
| Albert, U; Bogetto, F; Maina, G; Rosso, G | 1 |
| Botts, S; Castro, FE; Cogollo, M; de Leon, J; Diaz, FJ; Muscatello, MR; Santoro, V; Spina, E | 1 |
| Adams, DH; Brown, E; Degenhardt, E; Dunner, DL; Houston, JP; Keck, PE; McElroy, SL; Tohen, M | 1 |
| Bakare, A; Cui, J; Shao, L; Wang, JF; Young, LT | 1 |
| Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
| Sillence, D; Tchan, MC | 1 |
| Adams, DH; Breier, A; Farmen, M; Fijal, B; Houston, JP; Perlis, RH; Sutton, VK | 1 |
| Bowden, C; Goodwin, GM; Grunze, H; Kasper, S; Licht, RW; Möller, HJ; Vieta, E | 1 |
| Lazarus, A; Quon, P; Tafesse, E; Woodward, TC | 1 |
| Aström, M; Chatterton, ML; Ekman, M; Günther, O; Locklear, J; Miltenburger, C; Paulsson, B; Vieta, E | 1 |
| Brecher, M; Calabrese, JR; Carlson, BX; Edwards, S; Eudicone, JM; Evoniuk, G; Ganocy, SJ; Jansen, W; Kemp, DE; Leon, AC; Minkwitz, M; Pikalov, A; Stassen, HH; Szegedi, A; Tohen, M; Van Willigenburg, AP | 1 |
| Frye, MA | 1 |
| Dadić-Hero, E; Frančišković, T; Graovac, M; Kaštelan, A; Rebić, J; Ružić, K | 1 |
| Yamada, K | 1 |
| Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T | 1 |
| Dore, J; Hill, SJ; Hooshmand, F; Ketter, TA; Miller, S; Portillo, N; Wang, PW | 1 |
| Lee, MS; Lo, MC; Pan, PY; Yang, EL; Yeh, CB | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Amato, L; Indave, BI; Minozzi, S; Pani, PP | 1 |
| Alda, M; Beaulieu, S; Berk, M; Bond, DJ; Calabrese, JR; Frey, BN; Goldstein, BI; Kanba, S; Kapczinski, F; Kennedy, SH; Kozicky, J; Lafer, B; Lam, RW; MacQueen, G; Malhi, G; McIntosh, D; McIntyre, RS; Milev, RV; O'Donovan, C; Parikh, SV; Post, RM; Ravindran, A; Rej, S; Schaffer, A; Sharma, V; Suppes, T; Vazquez, G; Vieta, E; Yatham, LN | 1 |
| Roosen, L; Sienaert, P | 1 |
| Jauhar, S; Kaufman, KR; Kerr-Gaffney, J; Kurana, S; Strawbridge, R; Yalin, N; Young, AH | 1 |
| Nabekura, T; Uwai, Y | 1 |
| Leucht, S; Mavridis, D; Siafis, S; Vieta, E; Yildiz, A | 1 |
29 review(s) available for lamotrigine and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New treatments of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Olanzapine; Phenytoin; Pirenzepine; Topiramate; Treatment Outcome; Triazines | 1999 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
Treating bipolar depression.
Topics: Acetates; Affect; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Lithium Compounds; Nipecotic Acids; Olanzapine; Oxcarbazepine; Pirenzepine; Tiagabine; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Zonisamide | 2003 |
Long-term therapy of bipolar illness.
Topics: Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Humans; Lamotrigine; Lithium Compounds; Olanzapine; Pirenzepine; Secondary Prevention; Time Factors; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Selecting effective long-term treatment for bipolar patients: monotherapy and combinations.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Long-Term Care; Olanzapine; Pirenzepine; Treatment Outcome; Triazines | 2003 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid | 2003 |
An overview of primary care assessment and management of bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic Errors; Humans; Lamotrigine; Lithium; Olanzapine; Primary Health Care; Triazines; Valproic Acid | 2004 |
Strategies for preventing the recurrence of bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Patient Education as Topic; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Triazines; Valproic Acid | 2004 |
Major advances in bipolar disorder.
Topics: Antimanic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Humans; Lamotrigine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Suicide; Triazines | 2004 |
Bipolar depression: an overview.
Topics: Acute Disease; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chemoprevention; Contraindications; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Triazines; Valproic Acid | 2004 |
Employing pharmacologic treatment of bipolar disorder to greatest effect.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Receptors, GABA; Receptors, Glutamate; Treatment Outcome; Triazines; Valproic Acid | 2004 |
Treatment options for bipolar depression.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Patient Education as Topic; Psychotherapy; Psychotherapy, Group; Secondary Prevention; Survival Analysis; Triazines | 2005 |
Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Counseling; Dibenzothiazepines; Family Planning Services; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Teratogens; Triazines; Valproic Acid; Women's Health | 2005 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Canada; Chronic Disease; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Humans; Lamotrigine; Lithium Carbonate; Mass Screening; Mood Disorders; Olanzapine; Personality Disorders; Prevalence; Quality of Life; Risk Factors; Substance-Related Disorders; Triazines; Valproic Acid | 2005 |
Newer treatment studies for bipolar depression.
Topics: Acetamides; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dopamine Agonists; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Lamotrigine; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Secondary Prevention; Transcranial Magnetic Stimulation; Triazines | 2005 |
Maintenance treatment of bipolar disorder: Applying research to clinical practice.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Evidence-Based Medicine; Humans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Quinolones; Triazines; Valproic Acid | 2006 |
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Lamotrigine; Olanzapine; Prevalence; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Treatment Outcome; Triazines | 2007 |
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Databases, Bibliographic; Female; Humans; Lamotrigine; Lithium; Male; Models, Economic; Olanzapine; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Secondary Prevention; Triazines; Valproic Acid | 2007 |
[Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?].
Topics: Adrenergic Antagonists; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Humans; Lamotrigine; Olanzapine; Prazosin; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Failure; Triazines | 2007 |
Treatment options for bipolar depression: a systematic review of randomized, controlled trials.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Treatment Outcome; Triazines | 2010 |
Clinical practice. Bipolar disorder--a focus on depression.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Dibenzothiazepines; Drug Combinations; Female; Fluoxetine; Humans; Lamotrigine; Olanzapine; Practice Guidelines as Topic; Psychotherapy; Quetiapine Fumarate; Triazines | 2011 |
[Evidence of treatment for depressive episodes of bipolar disorder].
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Electroconvulsive Therapy; Episode of Care; Evidence-Based Medicine; Humans; Lamotrigine; Lithium Compounds; Meta-Analysis as Topic; Olanzapine; Practice Guidelines as Topic; Quetiapine Fumarate; Triazines | 2011 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Antipsychotic medications for cocaine dependence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cocaine-Related Disorders; Haloperidol; Humans; Lamotrigine; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reserpine; Risperidone; Triazines | 2016 |
Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Valproic Acid | 2022 |
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.
Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2022 |
Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
Topics: Adult; Bipolar Disorder; Depression; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Humans; Lamotrigine; Lurasidone Hydrochloride; Male; Middle Aged; Network Meta-Analysis; Olanzapine; Quetiapine Fumarate | 2023 |
10 trial(s) available for lamotrigine and olanzapine
| Article | Year |
|---|---|
Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Area Under Curve; Benzodiazepines; Central Nervous System Agents; Drug Administration Schedule; Drug Interactions; Humans; Lamotrigine; Male; Olanzapine; Triazines | 2006 |
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lamotrigine; Male; Olanzapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Severity of Illness Index; Treatment Outcome; Triazines | 2006 |
Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Drug Interactions; Female; Humans; Lamotrigine; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Triazines | 2006 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
Simultaneous high-performance liquid chromatographic determination of olanzapine and lamotrigine in plasma of bipolar patients.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chromatography, High Pressure Liquid; Humans; Lamotrigine; Molecular Structure; Olanzapine; Triazines | 2007 |
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Olanzapine; Pilot Projects; Single-Blind Method; Triazines | 2008 |
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
Topics: Adolescent; Adult; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lamotrigine; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome; Triazines; Young Adult | 2009 |
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzodiazepines; Bipolar Disorder; Dopamine beta-Hydroxylase; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Fluoxetine; Genetic Association Studies; Genotype; Humans; Lamotrigine; Male; Olanzapine; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptor, Melanocortin, Type 2; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Glucocorticoid; Receptors, Histamine H1; Treatment Outcome; Triazines | 2010 |
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome; Triazines | 2011 |
Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Female; Humans; Lamotrigine; Male; Middle Aged; Olanzapine; Prospective Studies; Treatment Outcome; Triazines | 2014 |
31 other study(ies) available for lamotrigine and olanzapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.
Topics: Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Fructose; Humans; Lamotrigine; Male; Obesity; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Triazines | 2002 |
Normalization of impaired cognitive functions failed to improve clinical symptomatology in a schizophrenic patient.
Topics: Acute Disease; Adolescent; Antipsychotic Agents; Benzodiazepines; Brain; Cognition Disorders; Electroencephalography; Humans; Lamotrigine; Male; Neuropsychological Tests; Olanzapine; Recovery of Function; Schizophrenia; Severity of Illness Index; Triazines | 2004 |
Outcome measurement, outcome management and monitoring.
Topics: Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Monitoring; Humans; Lamotrigine; Lithium Carbonate; Olanzapine; Outcome and Process Assessment, Health Care; Surveys and Questionnaires; Treatment Outcome; Triazines; Valproic Acid | 2005 |
Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delusions; Excitatory Amino Acid Antagonists; Female; Hallucinations; Humans; Lamotrigine; Magnetic Resonance Imaging; Multiple Sclerosis; Olanzapine; Pain; Psychotic Disorders; Risperidone; Temporal Lobe; Triazines; Weight Gain | 2006 |
Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Area Under Curve; Benzodiazepines; Cohort Studies; Drug Interactions; Female; Half-Life; Humans; Lamotrigine; Male; Middle Aged; Olanzapine; Prospective Studies; Triazines | 2006 |
A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Capsules; Carbamazepine; Child; Child, Preschool; Delayed-Action Preparations; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Olanzapine; Oxcarbazepine; Retrospective Studies; Treatment Outcome; Triazines; Valproic Acid | 2006 |
The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Humans; Lamotrigine; Lithium Compounds; Models, Economic; Olanzapine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Triazines | 2006 |
Lamotrigine-induced severe manic switch.
Topics: Adolescent; Affective Disorders, Psychotic; Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lamotrigine; Lithium Compounds; Male; Olanzapine; Triazines | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbamazepine; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Triazines; Valproic Acid | 2007 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
Topics: Acute Disease; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Canada; Comorbidity; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lamotrigine; Lithium Carbonate; Mood Disorders; Olanzapine; Quetiapine Fumarate; Triazines; Valproic Acid | 2006 |
[Vigency of lithium treatment].
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Controlled Clinical Trials as Topic; Depression; Fructose; Humans; Lamotrigine; Lithium Compounds; Neuroprotective Agents; Olanzapine; Topiramate; Triazines | 2007 |
Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
Topics: Adult; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Observation; Observer Variation; Olanzapine; Treatment Outcome; Triazines; Valproic Acid | 2007 |
The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Follow-Up Studies; Humans; Lamotrigine; Olanzapine; Personality Assessment; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome; Triazines | 2008 |
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model.
Topics: Adult; Algorithms; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Lamotrigine; Linear Models; Male; Middle Aged; Olanzapine; Regression Analysis; Smoking; Triazines; Valproic Acid | 2008 |
Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Cells, Cultured; Cerebral Cortex; Glutathione Transferase; Lamotrigine; Neurons; Olanzapine; Rats; Rats, Sprague-Dawley; Triazines | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child, Preschool; Cohort Studies; Female; Humans; Incidence; Lamotrigine; Male; Mental Disorders; Mucopolysaccharidosis III; Olanzapine; Risperidone; Triazines; Young Adult | 2009 |
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Dibenzothiazepines; Electroconvulsive Therapy; Humans; Lamotrigine; Lithium Compounds; Olanzapine; Psychiatric Status Rating Scales; Psychotherapy; Quetiapine Fumarate; Triazines; Valproic Acid | 2010 |
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Topics: Absenteeism; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Fees, Pharmaceutical; Health Care Costs; Hospital Charges; Humans; Lamotrigine; Lithium Compounds; Markov Chains; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Quinolones; Risk; Tablets; Triazines; United States; Valproic Acid | 2010 |
Weight gain induced with olanzapine in adolescent.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cooperative Behavior; Delayed-Action Preparations; Dibenzothiazepines; Drug Substitution; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Interdisciplinary Communication; Lamotrigine; Neurocognitive Disorders; Olanzapine; Quetiapine Fumarate; Triazines; Weight Gain | 2011 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Carbamazepine; Causality; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Galactorrhea; Humans; Lamotrigine; Logistic Models; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Switzerland; Triazines; Valproic Acid; Weight Gain; Young Adult | 2013 |
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Topics: Academic Medical Centers; Adult; Ambulatory Care Facilities; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; California; Dibenzothiazepines; Drug Therapy; Female; Humans; Lamotrigine; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Referral and Consultation; Risperidone; Triazines | 2014 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Topics: Adolescent; Aged; Algorithms; Antipsychotic Agents; Bipolar Disorder; Bupropion; Child; Evidence-Based Medicine; Female; Humans; Lamotrigine; Lithium Compounds; Olanzapine; Quetiapine Fumarate; Societies, Medical; Suicide; Suicide Prevention; Valproic Acid | 2018 |
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Japan; Lamotrigine; Lithium Carbonate; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |